RNF2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.029000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.491400E-01
Normal-vs-Stage2
7.750200E-01
Normal-vs-Stage3
1.416380E-01
Normal-vs-Stage4
1.009200E-01
Stage1-vs-Stage2
4.775400E-01
Stage1-vs-Stage3
1.404630E-01
Stage1-vs-Stage4
3.386000E-01
Stage2-vs-Stage3
1.301440E-01
Stage2-vs-Stage4
4.157800E-02
Stage3-vs-Stage4
1.626420E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.452600E-01
Normal-vs-AfricanAmerican
1.218170E-01
Normal-vs-Asian
8.432400E-01
Caucasian-vs-AfricanAmerican
2.702600E-01
Caucasian-vs-Asian
9.710000E-01
AfricanAmerican-vs-Asian
3.385400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.433800E-01
Normal-vs-Female
8.887000E-01
Male-vs-Female
2.998400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.392200E-01
Normal-vs-Age(41-60Yrs)
5.569000E-01
Normal-vs-Age(61-80Yrs)
8.900200E-01
Normal-vs-Age(81-100Yrs)
5.771600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.392000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.391000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.075600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.118400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.083400E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.471000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.765200E-01
Normal-vs-Daily Drinker
7.135600E-01
Normal-vs-Weekly Drinker
8.883000E-01
Normal-vs-Occasional Drinker
3.331200E-01
Normal-vs-Social Drinker
9.780800E-01
Non Drinker-vs-Daily Drinker
4.460400E-01
Non Drinker-vs-Weekly Drinker
7.323400E-01
Non Drinker-vs-Occasional Drinker
2.531900E-02
Non Drinker-vs-Social Drinker
9.236000E-01
Daily Drinker-vs-Weekly Drinker
3.807600E-01
Daily Drinker-vs-Occasional Drinker
1.189580E-02
Daily Drinker-vs-Social Drinker
5.463400E-01
Weekly Drinker-vs-Occasional Drinker
1.495790E-01
Weekly Drinker-vs-Social Drinker
8.884800E-01
Occasional Drinker-vs-Social Drinker
1.573000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.219370E-01
Normal-vs-Grade 2
9.495700E-03
Normal-vs-Grade 3
3.091600E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.221700E-03
Grade 1-vs-Grade 3
9.018700E-03
Grade 1-vs-Grade 4
1.219370E-01
Grade 2-vs-Grade 3
4.989800E-01
Grade 2-vs-Grade 4
9.495700E-03
Grade 3-vs-Grade 4
3.091600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.815000E-01
Normal-vs-NonDiabetic
8.290000E-01
Diabetic-vs-NonDiabetic
4.759000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.052400E-01
Normal-vs-NoPancreatitis
8.546200E-01
Pancreatitis-vs-NoPancreatitis
5.774200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.256600E-01
Normal-vs-N1
7.855600E-01
N0-vs-N1
9.606600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.096200E-01
Normal-vs-TP53-NonMutant
8.558000E-01
TP53-Mutant-vs-TP53-NonMutant
1.843750E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
